Global β2 Adrenoceptor Agonists Market Size, Status and Forecast 2024-2031

Report ID: 918271 | Published Date: Dec 2025 | No. of Page: 129 | Base Year: 2024 | Rating: 4.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%)

Impact of U.S Tarrifs Analyzed 2025 

1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global β2 Adrenoceptor Agonists Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Albuterol
        1.2.3 Terbutaline
        1.2.4 Salmeterol
        1.2.5 Formoterol
        1.2.6 Pirbuterol
    1.3 Market by Application
        1.3.1 Global β2 Adrenoceptor Agonists Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Bronchial Asthma
        1.3.3 Asthmatic Bronchitis
        1.3.4 Emphysema
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global β2 Adrenoceptor Agonists Market Perspective (2016-2027)
    2.2 β2 Adrenoceptor Agonists Growth Trends by Regions
        2.2.1 β2 Adrenoceptor Agonists Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 β2 Adrenoceptor Agonists Historic Market Share by Regions (2016-2021)
        2.2.3 β2 Adrenoceptor Agonists Forecasted Market Size by Regions (2022-2027)
    2.3 β2 Adrenoceptor Agonists Industry Dynamic
        2.3.1 β2 Adrenoceptor Agonists Market Trends
        2.3.2 β2 Adrenoceptor Agonists Market Drivers
        2.3.3 β2 Adrenoceptor Agonists Market Challenges
        2.3.4 β2 Adrenoceptor Agonists Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top β2 Adrenoceptor Agonists Players by Revenue
        3.1.1 Global Top β2 Adrenoceptor Agonists Players by Revenue (2016-2021)
        3.1.2 Global β2 Adrenoceptor Agonists Revenue Market Share by Players (2016-2021)
    3.2 Global β2 Adrenoceptor Agonists Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by β2 Adrenoceptor Agonists Revenue
    3.4 Global β2 Adrenoceptor Agonists Market Concentration Ratio
        3.4.1 Global β2 Adrenoceptor Agonists Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by β2 Adrenoceptor Agonists Revenue in 2020
    3.5 β2 Adrenoceptor Agonists Key Players Head office and Area Served
    3.6 Key Players β2 Adrenoceptor Agonists Product Solution and Service
    3.7 Date of Enter into β2 Adrenoceptor Agonists Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 β2 Adrenoceptor Agonists Breakdown Data by Type
    4.1 Global β2 Adrenoceptor Agonists Historic Market Size by Type (2016-2021)
    4.2 Global β2 Adrenoceptor Agonists Forecasted Market Size by Type (2022-2027)

5 β2 Adrenoceptor Agonists Breakdown Data by Application
    5.1 Global β2 Adrenoceptor Agonists Historic Market Size by Application (2016-2021)
    5.2 Global β2 Adrenoceptor Agonists Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America β2 Adrenoceptor Agonists Market Size (2016-2027)
    6.2 North America β2 Adrenoceptor Agonists Market Size by Type
        6.2.1 North America β2 Adrenoceptor Agonists Market Size by Type (2016-2021)
        6.2.2 North America β2 Adrenoceptor Agonists Market Size by Type (2022-2027)
        6.2.3 North America β2 Adrenoceptor Agonists Market Size by Type (2016-2027)
    6.3 North America β2 Adrenoceptor Agonists Market Size by Application
        6.3.1 North America β2 Adrenoceptor Agonists Market Size by Application (2016-2021)
        6.3.2 North America β2 Adrenoceptor Agonists Market Size by Application (2022-2027)
        6.3.3 North America β2 Adrenoceptor Agonists Market Size by Application (2016-2027)
    6.4 North America β2 Adrenoceptor Agonists Market Size by Country
        6.4.1 North America β2 Adrenoceptor Agonists Market Size by Country (2016-2021)
        6.4.2 North America β2 Adrenoceptor Agonists Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe β2 Adrenoceptor Agonists Market Size (2016-2027)
    7.2 Europe β2 Adrenoceptor Agonists Market Size by Type
        7.2.1 Europe β2 Adrenoceptor Agonists Market Size by Type (2016-2021)
        7.2.2 Europe β2 Adrenoceptor Agonists Market Size by Type (2022-2027)
        7.2.3 Europe β2 Adrenoceptor Agonists Market Size by Type (2016-2027)
    7.3 Europe β2 Adrenoceptor Agonists Market Size by Application
        7.3.1 Europe β2 Adrenoceptor Agonists Market Size by Application (2016-2021)
        7.3.2 Europe β2 Adrenoceptor Agonists Market Size by Application (2022-2027)
        7.3.3 Europe β2 Adrenoceptor Agonists Market Size by Application (2016-2027)
    7.4 Europe β2 Adrenoceptor Agonists Market Size by Country
        7.4.1 Europe β2 Adrenoceptor Agonists Market Size by Country (2016-2021)
        7.4.2 Europe β2 Adrenoceptor Agonists Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific β2 Adrenoceptor Agonists Market Size (2016-2027)
    8.2 Asia-Pacific β2 Adrenoceptor Agonists Market Size by Type
        8.2.1 Asia-Pacific β2 Adrenoceptor Agonists Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific β2 Adrenoceptor Agonists Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific β2 Adrenoceptor Agonists Market Size by Type (2016-2027)
    8.3 Asia-Pacific β2 Adrenoceptor Agonists Market Size by Application
        8.3.1 Asia-Pacific β2 Adrenoceptor Agonists Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific β2 Adrenoceptor Agonists Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific β2 Adrenoceptor Agonists Market Size by Application (2016-2027)
    8.4 Asia-Pacific β2 Adrenoceptor Agonists Market Size by Region
        8.4.1 Asia-Pacific β2 Adrenoceptor Agonists Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific β2 Adrenoceptor Agonists Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America β2 Adrenoceptor Agonists Market Size (2016-2027)
    9.2 Latin America β2 Adrenoceptor Agonists Market Size by Type
        9.2.1 Latin America β2 Adrenoceptor Agonists Market Size by Type (2016-2021)
        9.2.2 Latin America β2 Adrenoceptor Agonists Market Size by Type (2022-2027)
        9.2.3 Latin America β2 Adrenoceptor Agonists Market Size by Type (2016-2027)
    9.3 Latin America β2 Adrenoceptor Agonists Market Size by Application
        9.3.1 Latin America β2 Adrenoceptor Agonists Market Size by Application (2016-2021)
        9.3.2 Latin America β2 Adrenoceptor Agonists Market Size by Application (2022-2027)
        9.3.3 Latin America β2 Adrenoceptor Agonists Market Size by Application (2016-2027)
    9.4 Latin America β2 Adrenoceptor Agonists Market Size by Country
        9.4.1 Latin America β2 Adrenoceptor Agonists Market Size by Country (2016-2021)
        9.4.2 Latin America β2 Adrenoceptor Agonists Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa β2 Adrenoceptor Agonists Market Size (2016-2027)
    10.2 Middle East & Africa β2 Adrenoceptor Agonists Market Size by Type
        10.2.1 Middle East & Africa β2 Adrenoceptor Agonists Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa β2 Adrenoceptor Agonists Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa β2 Adrenoceptor Agonists Market Size by Type (2016-2027)
    10.3 Middle East & Africa β2 Adrenoceptor Agonists Market Size by Application
        10.3.1 Middle East & Africa β2 Adrenoceptor Agonists Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa β2 Adrenoceptor Agonists Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa β2 Adrenoceptor Agonists Market Size by Application (2016-2027)
    10.4 Middle East & Africa β2 Adrenoceptor Agonists Market Size by Country
        10.4.1 Middle East & Africa β2 Adrenoceptor Agonists Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa β2 Adrenoceptor Agonists Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Ivax Pharmaceuticals 
        11.1.1 Ivax Pharmaceuticals  Company Details
        11.1.2 Ivax Pharmaceuticals  Business Overview
        11.1.3 Ivax Pharmaceuticals  β2 Adrenoceptor Agonists Introduction
        11.1.4 Ivax Pharmaceuticals  Revenue in β2 Adrenoceptor Agonists Business (2016-2021)
        11.1.5 Ivax Pharmaceuticals  Recent Development
    11.2 Physicians Total Care
        11.2.1 Physicians Total Care Company Details
        11.2.2 Physicians Total Care Business Overview
        11.2.3 Physicians Total Care β2 Adrenoceptor Agonists Introduction
        11.2.4 Physicians Total Care Revenue in β2 Adrenoceptor Agonists Business (2016-2021)
        11.2.5 Physicians Total Care Recent Development
    11.3 Baxter Healthcare 
        11.3.1 Baxter Healthcare  Company Details
        11.3.2 Baxter Healthcare  Business Overview
        11.3.3 Baxter Healthcare  β2 Adrenoceptor Agonists Introduction
        11.3.4 Baxter Healthcare  Revenue in β2 Adrenoceptor Agonists Business (2016-2021)
        11.3.5 Baxter Healthcare  Recent Development
    11.4 Sanofi
        11.4.1 Sanofi Company Details
        11.4.2 Sanofi Business Overview
        11.4.3 Sanofi β2 Adrenoceptor Agonists Introduction
        11.4.4 Sanofi Revenue in β2 Adrenoceptor Agonists Business (2016-2021)
        11.4.5 Sanofi Recent Development
    11.5 Pfizer
        11.5.1 Pfizer Company Details
        11.5.2 Pfizer Business Overview
        11.5.3 Pfizer β2 Adrenoceptor Agonists Introduction
        11.5.4 Pfizer Revenue in β2 Adrenoceptor Agonists Business (2016-2021)
        11.5.5 Pfizer Recent Development
    11.6 Bedford Laboratories
        11.6.1 Bedford Laboratories Company Details
        11.6.2 Bedford Laboratories Business Overview
        11.6.3 Bedford Laboratories β2 Adrenoceptor Agonists Introduction
        11.6.4 Bedford Laboratories Revenue in β2 Adrenoceptor Agonists Business (2016-2021)
        11.6.5 Bedford Laboratories Recent Development
    11.7 Novartis
        11.7.1 Novartis Company Details
        11.7.2 Novartis Business Overview
        11.7.3 Novartis β2 Adrenoceptor Agonists Introduction
        11.7.4 Novartis Revenue in β2 Adrenoceptor Agonists Business (2016-2021)
        11.7.5 Novartis Recent Development
    11.8 Sterimax
        11.8.1 Sterimax Company Details
        11.8.2 Sterimax Business Overview
        11.8.3 Sterimax β2 Adrenoceptor Agonists Introduction
        11.8.4 Sterimax Revenue in β2 Adrenoceptor Agonists Business (2016-2021)
        11.8.5 Sterimax Recent Development
    11.9 Teligent
        11.9.1 Teligent Company Details
        11.9.2 Teligent Business Overview
        11.9.3 Teligent β2 Adrenoceptor Agonists Introduction
        11.9.4 Teligent Revenue in β2 Adrenoceptor Agonists Business (2016-2021)
        11.9.5 Teligent Recent Development
    11.10 AstraZeneca
        11.10.1 AstraZeneca Company Details
        11.10.2 AstraZeneca Business Overview
        11.10.3 AstraZeneca β2 Adrenoceptor Agonists Introduction
        11.10.4 AstraZeneca Revenue in β2 Adrenoceptor Agonists Business (2016-2021)
        11.10.5 AstraZeneca Recent Development
    11.11 Hikma Pharmaceuticals
        11.11.1 Hikma Pharmaceuticals Company Details
        11.11.2 Hikma Pharmaceuticals Business Overview
        11.11.3 Hikma Pharmaceuticals β2 Adrenoceptor Agonists Introduction
        11.11.4 Hikma Pharmaceuticals Revenue in β2 Adrenoceptor Agonists Business (2016-2021)
        11.11.5 Hikma Pharmaceuticals Recent Development
    11.12 Av Kare
        11.12.1 Av Kare Company Details
        11.12.2 Av Kare Business Overview
        11.12.3 Av Kare β2 Adrenoceptor Agonists Introduction
        11.12.4 Av Kare Revenue in β2 Adrenoceptor Agonists Business (2016-2021)
        11.12.5 Av Kare Recent Development
    11.13 Impax Laboratories
        11.13.1 Impax Laboratories Company Details
        11.13.2 Impax Laboratories Business Overview
        11.13.3 Impax Laboratories β2 Adrenoceptor Agonists Introduction
        11.13.4 Impax Laboratories Revenue in β2 Adrenoceptor Agonists Business (2016-2021)
        11.13.5 Impax Laboratories Recent Development
    11.14 PD-Rx Pharmaceuticals
        11.14.1 PD-Rx Pharmaceuticals Company Details
        11.14.2 PD-Rx Pharmaceuticals Business Overview
        11.14.3 PD-Rx Pharmaceuticals β2 Adrenoceptor Agonists Introduction
        11.14.4 PD-Rx Pharmaceuticals Revenue in β2 Adrenoceptor Agonists Business (2016-2021)
        11.14.5 PD-Rx Pharmaceuticals Recent Development
    11.15 Athenex Pharmaceutical Division
        11.15.1 Athenex Pharmaceutical Division Company Details
        11.15.2 Athenex Pharmaceutical Division Business Overview
        11.15.3 Athenex Pharmaceutical Division β2 Adrenoceptor Agonists Introduction
        11.15.4 Athenex Pharmaceutical Division Revenue in β2 Adrenoceptor Agonists Business (2016-2021)
        11.15.5 Athenex Pharmaceutical Division Recent Development
    11.16 Teva
        11.16.1 Teva Company Details
        11.16.2 Teva Business Overview
        11.16.3 Teva β2 Adrenoceptor Agonists Introduction
        11.16.4 Teva Revenue in β2 Adrenoceptor Agonists Business (2016-2021)
        11.16.5 Teva Recent Development
    11.17 Marlex Pharmaceuticals
        11.17.1 Marlex Pharmaceuticals Company Details
        11.17.2 Marlex Pharmaceuticals Business Overview
        11.17.3 Marlex Pharmaceuticals β2 Adrenoceptor Agonists Introduction
        11.17.4 Marlex Pharmaceuticals Revenue in β2 Adrenoceptor Agonists Business (2016-2021)
        11.17.5 Marlex Pharmaceuticals Recent Development
    11.18 Lannett Company
        11.18.1 Lannett Company Company Details
        11.18.2 Lannett Company Business Overview
        11.18.3 Lannett Company β2 Adrenoceptor Agonists Introduction
        11.18.4 Lannett Company Revenue in β2 Adrenoceptor Agonists Business (2016-2021)
        11.18.5 Lannett Company Recent Development
    11.18 West-Ward Pharmaceuticals
        .1 West-Ward Pharmaceuticals Company Details
        .2 West-Ward Pharmaceuticals Business Overview
        .3 West-Ward Pharmaceuticals β2 Adrenoceptor Agonists Introduction
        .4 West-Ward Pharmaceuticals Revenue in β2 Adrenoceptor Agonists Business (2016-2021)
        .5 West-Ward Pharmaceuticals Recent Development
    11.20 United Biomedical
        11.20.1 United Biomedical Company Details
        11.20.2 United Biomedical Business Overview
        11.20.3 United Biomedical β2 Adrenoceptor Agonists Introduction
        11.20.4 United Biomedical Revenue in β2 Adrenoceptor Agonists Business (2016-2021)
        11.20.5 United Biomedical Recent Development
    11.21 Merck
        11.21.1 Merck Company Details
        11.21.2 Merck Business Overview
        11.21.3 Merck β2 Adrenoceptor Agonists Introduction
        11.21.4 Merck Revenue in β2 Adrenoceptor Agonists Business (2016-2021)
        11.21.5 Merck Recent Development
    11.22 Mylan
        11.22.1 Mylan Company Details
        11.22.2 Mylan Business Overview
        11.22.3 Mylan β2 Adrenoceptor Agonists Introduction
        11.22.4 Mylan Revenue in β2 Adrenoceptor Agonists Business (2016-2021)
        11.22.5 Mylan Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global β2 Adrenoceptor Agonists Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Albuterol
    Table 3. Key Players of Terbutaline
    Table 4. Key Players of Salmeterol
    Table 5. Key Players of Formoterol
    Table 6. Key Players of Pirbuterol
    Table 7. Global β2 Adrenoceptor Agonists Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 8. Global β2 Adrenoceptor Agonists Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 9. Global β2 Adrenoceptor Agonists Market Size by Regions (2016-2021) & (US$ Million)
    Table 10. Global β2 Adrenoceptor Agonists Market Share by Regions (2016-2021)
    Table 11. Global β2 Adrenoceptor Agonists Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 12. Global β2 Adrenoceptor Agonists Market Share by Regions (2022-2027)
    Table 13. β2 Adrenoceptor Agonists Market Trends
    Table 14. β2 Adrenoceptor Agonists Market Drivers
    Table 15. β2 Adrenoceptor Agonists Market Challenges
    Table 16. β2 Adrenoceptor Agonists Market Restraints
    Table 17. Global β2 Adrenoceptor Agonists Revenue by Players (2016-2021) & (US$ Million)
    Table 18. Global β2 Adrenoceptor Agonists Market Share by Players (2016-2021)
    Table 19. Global Top β2 Adrenoceptor Agonists Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in β2 Adrenoceptor Agonists as of 2020)
    Table 20. Ranking of Global Top β2 Adrenoceptor Agonists Companies by Revenue (US$ Million) in 2020
    Table 21. Global 5 Largest Players Market Share by β2 Adrenoceptor Agonists Revenue (CR5 and HHI) & (2016-2021)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players β2 Adrenoceptor Agonists Product Solution and Service
    Table 24. Date of Enter into β2 Adrenoceptor Agonists Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global β2 Adrenoceptor Agonists Market Size by Type (2016-2021) (US$ Million)
    Table 27. Global β2 Adrenoceptor Agonists Revenue Market Share by Type (2016-2021)
    Table 28. Global β2 Adrenoceptor Agonists Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 29. Global β2 Adrenoceptor Agonists Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 30. Global β2 Adrenoceptor Agonists Market Size Share by Application (2016-2021) & (US$ Million)
    Table 31. Global β2 Adrenoceptor Agonists Revenue Market Share by Application (2016-2021)
    Table 32. Global β2 Adrenoceptor Agonists Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 33. Global β2 Adrenoceptor Agonists Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 34. North America β2 Adrenoceptor Agonists Market Size by Type (2016-2021) (US$ Million)
    Table 35. North America β2 Adrenoceptor Agonists Market Size by Type (2022-2027) & (US$ Million)
    Table 36. North America β2 Adrenoceptor Agonists Market Size by Application (2016-2021) (US$ Million)
    Table 37. North America β2 Adrenoceptor Agonists Market Size by Application (2022-2027) & (US$ Million)
    Table 38. North America β2 Adrenoceptor Agonists Market Size by Country (2016-2021) & (US$ Million) 
    Table 39. North America β2 Adrenoceptor Agonists Market Size by Country (2022-2027) & (US$ Million) 
    Table 40. Europe β2 Adrenoceptor Agonists Market Size by Type (2016-2021) (US$ Million)
    Table 41. Europe β2 Adrenoceptor Agonists Market Size by Type (2022-2027) & (US$ Million)
    Table 42. Europe β2 Adrenoceptor Agonists Market Size by Application (2016-2021) (US$ Million)
    Table 43. Europe β2 Adrenoceptor Agonists Market Size by Application (2022-2027) & (US$ Million)
    Table 44. Europe β2 Adrenoceptor Agonists Market Size by Country (2016-2021) & (US$ Million) 
    Table 45. Europe β2 Adrenoceptor Agonists Market Size by Country (2022-2027) & (US$ Million) 
    Table 46. Asia-Pacific β2 Adrenoceptor Agonists Market Size by Type (2016-2021) (US$ Million)
    Table 47. Asia-Pacific β2 Adrenoceptor Agonists Market Size by Type (2022-2027) & (US$ Million)
    Table 48. Asia-Pacific β2 Adrenoceptor Agonists Market Size by Application (2016-2021) (US$ Million)
    Table 49. Asia-Pacific β2 Adrenoceptor Agonists Market Size by Application (2022-2027) & (US$ Million)
    Table 50. Asia-Pacific β2 Adrenoceptor Agonists Market Size by Region (2016-2021) & (US$ Million) 
    Table 51. Asia-Pacific β2 Adrenoceptor Agonists Market Size by Region (2022-2027) & (US$ Million) 
    Table 52. Latin America β2 Adrenoceptor Agonists Market Size by Type (2016-2021) (US$ Million)
    Table 53. Latin America β2 Adrenoceptor Agonists Market Size by Type (2022-2027) & (US$ Million)
    Table 54. Latin America β2 Adrenoceptor Agonists Market Size by Application (2016-2021) (US$ Million)
    Table 55. Latin America β2 Adrenoceptor Agonists Market Size by Application (2022-2027) & (US$ Million)
    Table 56. Latin America β2 Adrenoceptor Agonists Market Size by Country (2016-2021) & (US$ Million) 
    Table 57. Latin America β2 Adrenoceptor Agonists Market Size by Country (2022-2027) & (US$ Million) 
    Table 58. Middle East & Africa β2 Adrenoceptor Agonists Market Size by Type (2016-2021) (US$ Million)
    Table 59. Middle East & Africa β2 Adrenoceptor Agonists Market Size by Type (2022-2027) & (US$ Million)
    Table 60. Middle East & Africa β2 Adrenoceptor Agonists Market Size by Application (2016-2021) (US$ Million)
    Table 61. Middle East & Africa β2 Adrenoceptor Agonists Market Size by Application (2022-2027) & (US$ Million)
    Table 62. Middle East & Africa β2 Adrenoceptor Agonists Market Size by Country (2016-2021) & (US$ Million) 
    Table 63. Middle East & Africa β2 Adrenoceptor Agonists Market Size by Country (2022-2027) & (US$ Million) 
    Table 64. Ivax Pharmaceuticals  Company Details
    Table 65. Ivax Pharmaceuticals  Business Overview
    Table 66. Ivax Pharmaceuticals  β2 Adrenoceptor Agonists Product
    Table 67. Ivax Pharmaceuticals  Revenue in β2 Adrenoceptor Agonists Business (2016-2021) & (US$ Million)
    Table 68. Ivax Pharmaceuticals  Recent Development
    Table 69. Physicians Total Care Company Details
    Table 70. Physicians Total Care Business Overview
    Table 71. Physicians Total Care β2 Adrenoceptor Agonists Product
    Table 72. Physicians Total Care Revenue in β2 Adrenoceptor Agonists Business (2016-2021) & (US$ Million)
    Table 73. Physicians Total Care Recent Development
    Table 74. Baxter Healthcare  Company Details
    Table 75. Baxter Healthcare  Business Overview
    Table 76. Baxter Healthcare  β2 Adrenoceptor Agonists Product
    Table 77. Baxter Healthcare  Revenue in β2 Adrenoceptor Agonists Business (2016-2021) & (US$ Million)
    Table 78. Baxter Healthcare  Recent Development
    Table 79. Sanofi Company Details
    Table 80. Sanofi Business Overview
    Table 81. Sanofi β2 Adrenoceptor Agonists Product
    Table 82. Sanofi Revenue in β2 Adrenoceptor Agonists Business (2016-2021) & (US$ Million)
    Table 83. Sanofi Recent Development
    Table 84. Pfizer Company Details
    Table 85. Pfizer Business Overview
    Table 86. Pfizer β2 Adrenoceptor Agonists Product
    Table 87. Pfizer Revenue in β2 Adrenoceptor Agonists Business (2016-2021) & (US$ Million)
    Table 88. Pfizer Recent Development
    Table 89. Bedford Laboratories Company Details
    Table 90. Bedford Laboratories Business Overview
    Table 91. Bedford Laboratories β2 Adrenoceptor Agonists Product
    Table 92. Bedford Laboratories Revenue in β2 Adrenoceptor Agonists Business (2016-2021) & (US$ Million)
    Table 93. Bedford Laboratories Recent Development
    Table 94. Novartis Company Details
    Table 95. Novartis Business Overview
    Table 96. Novartis β2 Adrenoceptor Agonists Product
    Table 97. Novartis Revenue in β2 Adrenoceptor Agonists Business (2016-2021) & (US$ Million)
    Table 98. Novartis Recent Development
    Table 99. Sterimax Company Details
    Table 100. Sterimax Business Overview
    Table 101. Sterimax Revenue in β2 Adrenoceptor Agonists Business (2016-2021) & (US$ Million)
    Table 102. Sterimax Recent Development
    Table 103. Teligent Company Details
    Table 104. Teligent Business Overview
    Table 105. Teligent β2 Adrenoceptor Agonists Product
    Table 106. Teligent Revenue in β2 Adrenoceptor Agonists Business (2016-2021) & (US$ Million)
    Table 107. Teligent Recent Development
    Table 108. AstraZeneca Company Details
    Table 109. AstraZeneca Business Overview
    Table 110. AstraZeneca β2 Adrenoceptor Agonists Product
    Table 111. AstraZeneca Revenue in β2 Adrenoceptor Agonists Business (2016-2021) & (US$ Million)
    Table 112. AstraZeneca Recent Development
    Table 113. Hikma Pharmaceuticals Company Details
    Table 114. Hikma Pharmaceuticals Business Overview
    Table 115. Hikma Pharmaceuticals β2 Adrenoceptor Agonists Product
    Table 116. Hikma Pharmaceuticals Revenue in β2 Adrenoceptor Agonists Business (2016-2021) & (US$ Million)
    Table 117. Hikma Pharmaceuticals Recent Development
    Table 118. Av Kare Company Details
    Table 119. Av Kare Business Overview
    Table 120. Av Kare β2 Adrenoceptor Agonists Product
    Table 121. Av Kare Revenue in β2 Adrenoceptor Agonists Business (2016-2021) & (US$ Million)
    Table 122. Av Kare Recent Development
    Table 123. Impax Laboratories Company Details
    Table 124. Impax Laboratories Business Overview
    Table 125. Impax Laboratories β2 Adrenoceptor Agonists Product
    Table 126. Impax Laboratories Revenue in β2 Adrenoceptor Agonists Business (2016-2021) & (US$ Million)
    Table 127. Impax Laboratories Recent Development
    Table 128. PD-Rx Pharmaceuticals Company Details
    Table 129. PD-Rx Pharmaceuticals Business Overview
    Table 130. PD-Rx Pharmaceuticals β2 Adrenoceptor Agonists Product
    Table 131. PD-Rx Pharmaceuticals Revenue in β2 Adrenoceptor Agonists Business (2016-2021) & (US$ Million)
    Table 132. PD-Rx Pharmaceuticals Recent Development
    Table 133. Athenex Pharmaceutical Division Company Details
    Table 134. Athenex Pharmaceutical Division Business Overview
    Table 135. Athenex Pharmaceutical Division β2 Adrenoceptor Agonists Product
    Table 136. Athenex Pharmaceutical Division Revenue in β2 Adrenoceptor Agonists Business (2016-2021) & (US$ Million)
    Table 137. Athenex Pharmaceutical Division Recent Development
    Table 138. Teva Company Details
    Table 139. Teva Business Overview
    Table 140. Teva β2 Adrenoceptor Agonists Product
    Table 141. Teva Revenue in β2 Adrenoceptor Agonists Business (2016-2021) & (US$ Million)
    Table 142. Teva Recent Development
    Table 143. Marlex Pharmaceuticals Company Details
    Table 144. Marlex Pharmaceuticals Business Overview
    Table 145. Marlex Pharmaceuticals β2 Adrenoceptor Agonists Product
    Table 146. Marlex Pharmaceuticals Revenue in β2 Adrenoceptor Agonists Business (2016-2021) & (US$ Million)
    Table 147. Marlex Pharmaceuticals Recent Development
    Table 148. Lannett Company Company Details
    Table 149. Lannett Company Business Overview
    Table 150. Lannett Company β2 Adrenoceptor Agonists Product
    Table 151. Lannett Company Revenue in β2 Adrenoceptor Agonists Business (2016-2021) & (US$ Million)
    Table 152. Lannett Company Recent Development
    Table 153. West-Ward Pharmaceuticals Company Details
    Table 154. West-Ward Pharmaceuticals Business Overview
    Table 155. West-Ward Pharmaceuticals β2 Adrenoceptor Agonists Product
    Table 156. West-Ward Pharmaceuticals Revenue in β2 Adrenoceptor Agonists Business (2016-2021) & (US$ Million)
    Table 157. West-Ward Pharmaceuticals Recent Development
    Table 158. United Biomedical Company Details
    Table 159. United Biomedical Business Overview
    Table 160. United Biomedical β2 Adrenoceptor Agonists Product
    Table 161. United Biomedical Revenue in β2 Adrenoceptor Agonists Business (2016-2021) & (US$ Million)
    Table 162. United Biomedical Recent Development
    Table 163. Merck Company Details
    Table 164. Merck Business Overview
    Table 165. Merck β2 Adrenoceptor Agonists Product
    Table 166. Merck Revenue in β2 Adrenoceptor Agonists Business (2016-2021) & (US$ Million)
    Table 167. Merck Recent Development
    Table 168. Mylan Company Details
    Table 169. Mylan Business Overview
    Table 170. Mylan β2 Adrenoceptor Agonists Product
    Table 171. Mylan Revenue in β2 Adrenoceptor Agonists Business (2016-2021) & (US$ Million)
    Table 172. Mylan Recent Development
    Table 173. Research Programs/Design for This Report
    Table 174. Key Data Information from Secondary Sources
    Table 175. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global β2 Adrenoceptor Agonists Market Share by Type: 2020 VS 2027
    Figure 2. Albuterol Features
    Figure 3. Terbutaline Features
    Figure 4. Salmeterol Features
    Figure 5. Formoterol Features
    Figure 6. Pirbuterol Features
    Figure 7. Global β2 Adrenoceptor Agonists Market Share by Application: 2020 VS 2027
    Figure 8. Bronchial Asthma Case Studies
    Figure 9. Asthmatic Bronchitis Case Studies
    Figure 10. Emphysema Case Studies
    Figure 11. Others Case Studies
    Figure 12. β2 Adrenoceptor Agonists Report Years Considered
    Figure 13. Global β2 Adrenoceptor Agonists Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 14. Global β2 Adrenoceptor Agonists Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 15. Global β2 Adrenoceptor Agonists Market Share by Regions: 2020 VS 2027
    Figure 16. Global β2 Adrenoceptor Agonists Market Share by Regions (2022-2027)
    Figure 17. Global β2 Adrenoceptor Agonists Market Share by Players in 2020
    Figure 18. Global Top β2 Adrenoceptor Agonists Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in β2 Adrenoceptor Agonists as of 2020
    Figure 19. The Top 10 and 5 Players Market Share by β2 Adrenoceptor Agonists Revenue in 2020
    Figure 20. Global β2 Adrenoceptor Agonists Revenue Market Share by Type (2016-2021)
    Figure 21. Global β2 Adrenoceptor Agonists Revenue Market Share by Type (2022-2027)
    Figure 22. North America β2 Adrenoceptor Agonists Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 23. North America β2 Adrenoceptor Agonists Market Share by Type (2016-2027)
    Figure 24. North America β2 Adrenoceptor Agonists Market Share by Application (2016-2027)
    Figure 25. North America β2 Adrenoceptor Agonists Market Share by Country (2016-2027)
    Figure 26. United States β2 Adrenoceptor Agonists Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 27. Canada β2 Adrenoceptor Agonists Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 28. Europe β2 Adrenoceptor Agonists Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. Europe β2 Adrenoceptor Agonists Market Share by Type (2016-2027)
    Figure 30. Europe β2 Adrenoceptor Agonists Market Share by Application (2016-2027)
    Figure 31. Europe β2 Adrenoceptor Agonists Market Share by Country (2016-2027)
    Figure 32. Germany β2 Adrenoceptor Agonists Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. France β2 Adrenoceptor Agonists Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. U.K. β2 Adrenoceptor Agonists Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Italy β2 Adrenoceptor Agonists Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Russia β2 Adrenoceptor Agonists Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Nordic β2 Adrenoceptor Agonists Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Asia-Pacific β2 Adrenoceptor Agonists Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Asia-Pacific β2 Adrenoceptor Agonists Market Share by Type (2016-2027)
    Figure 40. Asia-Pacific β2 Adrenoceptor Agonists Market Share by Application (2016-2027)
    Figure 41. Asia-Pacific β2 Adrenoceptor Agonists Market Share by Region (2016-2027)
    Figure 42. China β2 Adrenoceptor Agonists Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Japan β2 Adrenoceptor Agonists Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. South Korea β2 Adrenoceptor Agonists Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Southeast Asia β2 Adrenoceptor Agonists Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. India β2 Adrenoceptor Agonists Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Australia β2 Adrenoceptor Agonists Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. Latin America β2 Adrenoceptor Agonists Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Latin America β2 Adrenoceptor Agonists Market Share by Type (2016-2027)
    Figure 50. Latin America β2 Adrenoceptor Agonists Market Share by Application (2016-2027)
    Figure 51. Latin America β2 Adrenoceptor Agonists Market Share by Country (2016-2027)
    Figure 52. Mexico β2 Adrenoceptor Agonists Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Brazil β2 Adrenoceptor Agonists Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 54. Middle East & Africa β2 Adrenoceptor Agonists Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. Middle East & Africa β2 Adrenoceptor Agonists Market Share by Type (2016-2027)
    Figure 56. Middle East & Africa β2 Adrenoceptor Agonists Market Share by Application (2016-2027)
    Figure 57. Middle East & Africa β2 Adrenoceptor Agonists Market Share by Country (2016-2027)
    Figure 58. Turkey β2 Adrenoceptor Agonists Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. Saudi Arabia β2 Adrenoceptor Agonists Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 60. UAE β2 Adrenoceptor Agonists Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 61. Ivax Pharmaceuticals  Revenue Growth Rate in β2 Adrenoceptor Agonists Business (2016-2021)
    Figure 62. Physicians Total Care Revenue Growth Rate in β2 Adrenoceptor Agonists Business (2016-2021)
    Figure 63. Baxter Healthcare  Revenue Growth Rate in β2 Adrenoceptor Agonists Business (2016-2021)
    Figure 64. Sanofi Revenue Growth Rate in β2 Adrenoceptor Agonists Business (2016-2021)
    Figure 65. Pfizer Revenue Growth Rate in β2 Adrenoceptor Agonists Business (2016-2021)
    Figure 66. Bedford Laboratories Revenue Growth Rate in β2 Adrenoceptor Agonists Business (2016-2021)
    Figure 67. Novartis Revenue Growth Rate in β2 Adrenoceptor Agonists Business (2016-2021)
    Figure 68. Sterimax Revenue Growth Rate in β2 Adrenoceptor Agonists Business (2016-2021)
    Figure 69. Teligent Revenue Growth Rate in β2 Adrenoceptor Agonists Business (2016-2021)
    Figure 70. AstraZeneca Revenue Growth Rate in β2 Adrenoceptor Agonists Business (2016-2021)
    Figure 71. Hikma Pharmaceuticals Revenue Growth Rate in β2 Adrenoceptor Agonists Business (2016-2021)
    Figure 72. Av Kare Revenue Growth Rate in β2 Adrenoceptor Agonists Business (2016-2021)
    Figure 73. Impax Laboratories Revenue Growth Rate in β2 Adrenoceptor Agonists Business (2016-2021)
    Figure 74. PD-Rx Pharmaceuticals Revenue Growth Rate in β2 Adrenoceptor Agonists Business (2016-2021)
    Figure 75. Athenex Pharmaceutical Division Revenue Growth Rate in β2 Adrenoceptor Agonists Business (2016-2021)
    Figure 76. Teva Revenue Growth Rate in β2 Adrenoceptor Agonists Business (2016-2021)
    Figure 77. Marlex Pharmaceuticals Revenue Growth Rate in β2 Adrenoceptor Agonists Business (2016-2021)
    Figure 78. Lannett Company Revenue Growth Rate in β2 Adrenoceptor Agonists Business (2016-2021)
    Figure 79. West-Ward Pharmaceuticals Revenue Growth Rate in β2 Adrenoceptor Agonists Business (2016-2021)
    Figure 80. United Biomedical Revenue Growth Rate in β2 Adrenoceptor Agonists Business (2016-2021)
    Figure 81. Merck Revenue Growth Rate in β2 Adrenoceptor Agonists Business (2016-2021)
    Figure 82. Mylan Revenue Growth Rate in β2 Adrenoceptor Agonists Business (2016-2021)
    Figure 83. Bottom-up and Top-down Approaches for This Report
    Figure 84. Data Triangulation
    Figure 85. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Ivax Pharmaceuticals 
Physicians Total Care
Baxter Healthcare 
Sanofi
Pfizer
Bedford Laboratories
Novartis
Sterimax
Teligent
AstraZeneca
Hikma Pharmaceuticals
Av Kare
Impax Laboratories
PD-Rx Pharmaceuticals
Athenex Pharmaceutical Division
Teva
Marlex Pharmaceuticals
Lannett Company
West-Ward Pharmaceuticals
United Biomedical
Merck
Mylan
Frequently Asked Questions
β2 Adrenoceptor Agonists report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
β2 Adrenoceptor Agonists report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
β2 Adrenoceptor Agonists report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Isoprenaline

Market Analysis and Insights: Global Isoprenaline Market
The global Isoprenaline ma ... Read More

Phenylephrine

Market Analysis and Insights: Global Phenylephrine Market
The global Phenylephrine  ... Read More